What is Organon & Co.'s Market Cap?

Organon & Co.'s Market Cap is $3.6B, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s Enterprise Value?

Organon & Co.'s Enterprise Value is $11.0B, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s Trailing P/E?

Organon & Co.'s Trailing P/E is 17.3×, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s Price / Sales?

Organon & Co.'s Price / Sales is 0.6×, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s EV / Revenue?

Organon & Co.'s EV / Revenue is 1.8×, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s EV / EBITDA?

Organon & Co.'s EV / EBITDA is 8.3×, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s Revenue (TTM)?

Organon & Co.'s Revenue (TTM) is $6.1B, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s Net Income (TTM)?

Organon & Co.'s Net Income (TTM) is $209.0M, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s EBITDA?

Organon & Co.'s EBITDA is $1.3B, based on as-reported figures from SEC (XBRL) filings.

What is Organon & Co.'s Diluted EPS (TTM)?

Organon & Co.'s Diluted EPS (TTM) is 0.80, based on as-reported figures from SEC (XBRL) filings.

Organon & Co. (OGN) Financial Statements

Organon & Co.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00ZQRGW42

XNYS · usd

13.74▼ 0.02 (-0.11%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close13.75

Day's Range13.75 – 13.78

52-Week Range5.69 – 13.79

Volume1.6M

Avg Volume2.9M

Share Statistics

Shares Outstanding

Employees10.0K

ExchangeXNYS

Listed2021-05-14

Share count as of July 24, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Organon & Co. (OGN)

What is Organon & Co.'s Market Cap?: Organon & Co.'s Market Cap is $3.6B, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s Enterprise Value?: Organon & Co.'s Enterprise Value is $11.0B, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s Trailing P/E?: Organon & Co.'s Trailing P/E is 17.3×, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s Price / Sales?: Organon & Co.'s Price / Sales is 0.6×, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s EV / Revenue?: Organon & Co.'s EV / Revenue is 1.8×, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s EV / EBITDA?: Organon & Co.'s EV / EBITDA is 8.3×, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s Revenue (TTM)?: Organon & Co.'s Revenue (TTM) is $6.1B, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s Net Income (TTM)?: Organon & Co.'s Net Income (TTM) is $209.0M, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s EBITDA?: Organon & Co.'s EBITDA is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Organon & Co.'s Diluted EPS (TTM)?: Organon & Co.'s Diluted EPS (TTM) is 0.80, based on as-reported figures from SEC (XBRL) filings.